All Stories

  1. Subclavian crush syndrome AND subcutaneous ICD in primary prevention patients
  2. Inflammatory biomarkers in atrial fibrillation
  3. Do women benefit equally as men from the primary prevention implantable cardioverter-defibrillator?
  4. Atrial fibrillation monitoring to reduce thromboembolic risk: Selecting the patient and the monitoring device
  5. Atrial fibrillation monitoring to reduce thromboembolic risk: Selecting the patient and the monitoring device
  6. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review
  7. The unfinished issue of ischaemic stroke and embolic events during catheter ablation of atrial fibrillation
  8. Call for joint informed consent in athletes with inherited cardiac conditions
  9. The ABC risk score for patients with atrial fibrillation
  10. Letter by Providencia and Lambiase Regarding Article, “Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction”
  11. Results from a multicentre comparison of cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: is cryoablation more reproducible?
  12. Persistent Atrial Fibrillation
  13. Letter by Providencia and Lambiase Regarding Article, “Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death”
  14. Additional value of associating aortic valve calcification to coronary calcium as a gatekeeper for coronary tomography angiography
  15. Use of implantable cardioverter-defibrillators in athletes: A systematic review
  16. Utilização de cardioversores desfibrilhadores implantáveis em desportistas: revisão sistemática
  17. Authors' reply
  18. Atrial Fibrillation and Non-cardiovascular Diseases: A Systematic Review
  19. Cardiovascular Disease
  20. Improving risk stratification in non-ST-segment elevation myocardial infarction with combined assessment of GRACE and CRUSADE risk scores
  21. Higher contact-force values associated with better mid-term outcome of paroxysmal atrial fibrillation ablation using the SmartTouch™ catheter
  22. Meta-Analysis of the Influence of Chronic Kidney Disease on the Risk of Thromboembolism Among Patients With Nonvalvular Atrial Fibrillation
  23. Which method of left atrium size quantification is the most accurate to recognize thromboembolic risk in patients with non-valvular atrial fibrillation?
  24. Financial impact of adopting implantable loop recorder diagnostic for unexplained syncope compared with conventional diagnostic pathway in Portugal
  25. Post-acute management of the acquired long QT syndrome
  26. Can cardiac computed tomography predict cardiovascular events in asymptomatic type-2 diabetics?: results of a long term follow-up
  27. Dabigatran in the setting of catheter ablation of atrial fibrillation: the road ahead
  28. Pulmonary embolism risk stratification
  29. Evaluation of left atrial deformation to predict left atrial stasis in patients with non-valvular atrial fibrillation – a pilot-study
  30. Real‐Time Contact Force Sensing for Pulmonary Vein Isolation in the Setting of Paroxysmal Atrial Fibrillation: Procedural and 1‐Year Results
  31. Mortalidade cerebrovascular em Portugal: estaremos a colocar demasiada ênfase na hipertensão e a negligenciar a fibrilhação auricular?
  32. Mortalidade cerebrovascular em Portugal: estaremos a colocar demasiada ênfase na hipertensão e a negligenciar a fibrilhação auricular?
  33. Contrast-enhanced multidetector computed tomography: A new prognosticator in acute pulmonary embolism?
  34. Troponin rise in patients with atrial fibrillation: A marker of adverse prognosis and increased thromboembolic risk
  35. Chronic renal disease is associated with stroke and thromboembolism in atrial fibrillation independently from gender
  36. Contrast-enhanced multidetector computed tomography: A new prognosticator in acute pulmonary embolism?
  37. Letter to the Editor— When to implant an ICD following a myocardial infarction?
  38. Stroke prediction with an adjusted R-CHA2DS2VASc score in a cohort of patients with a Myocardial Infarction
  39. Chronic kidney disease: One step further in the refinement of risk stratification of atrial fibrillation and impact on the choice of anticoagulant
  40. Cardiac troponin I: Prothrombotic risk marker in non-valvular atrial fibrillation
  41. The Role of Echocardiography in Thromboembolic Risk Assessment of Patients with Nonvalvular Atrial Fibrillation
  42. Troponin rise and poor outcome in patients presenting to the ED with short-duration atrial fibrillation
  43. Atrial fibrillation, elevated troponin, ischemic stroke and adverse outcomes: understanding the connection
  44. Mean platelet volume is associated with the presence of left atrial stasis in patients with non-valvular atrial fibrillation
  45. Incessant slow bundle branch reentrant ventricular tachycardia in a young patient with left ventricular noncompaction
  46. Early Repolarization and Arrhythmia Death
  47. Encerramento percutâneo do apêndice auricular esquerdo para profilaxia de tromboembolismo na fibrilhação auricular em doentes com contraindicação ou falência da hipocoagulação oral: experiência de um serviço
  48. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: A single-center experience
  49. Incessant slow bundle branch reentrant ventricular tachycardia in a young patient with left ventricular noncompaction
  50. A Review on State‐of‐the‐Art Data Regarding Safe Early Discharge Following Admission for Pulmonary Embolism: What Do We Know?
  51. CHADS2 e CHA2DS2VASc como preditores de fonte cardioembólica em prevenção secundária cerebrovascular
  52. Encerramento percutâneo do apêndice auricular esquerdo para profilaxia de tromboembolismo na fibrilhação auricular
  53. Percutaneous closure of the left atrial appendage for thromboembolic prevention in atrial fibrillation
  54. Nesidioblastosis: an undescribed cause of transient loss of conscience in young adults
  55. Risk Stratification of Patients with Early Repolarization…Still an Unresolved Matter!
  56. Excluding the Presence of Left Atrial Thrombus Before Pulmonary Vein Isolation: “primum non nocere”!
  57. Cardiovascular Risk Assessment of Pulmonary Embolism With the GRACE Risk Score
  58. Early discharge and outpatient treatment of patients admitted for acute pulmonary embolism
  59. Holiday Heart Syndrome Revisited after 34 Years
  60. Is More Aggressive Prevention of Coronary Artery Disease Required for Patients With Early Repolarization Syndrome?
  61. Clinical correlates of early repolarization and J wave patterns…are they proarrhythmic on their own?
  62. The Use of the Chronic Kidney Disease Epidemiology Collaboration Equation and Global Cardiovascular Risk Assessment in Patients with Atrial Fibrillation
  63. Infecção recorrente em apresentação tardia de taquicardia ventricular polimórfica catecolaminérgica
  64. Decreased Glomerular Filtration Rate and Markers of Left Atrial Stasis in Patients with Nonvalvular Atrial Fibrillation
  65. Left ventricular mass as a discriminator of left atrial appendage thrombus in persistent atrial fibrillation: promise or over-enthusiasm?
  66. Cardioversion safety in patients with nonvalvular atrial fibrillation
  67. LR–PED Rule: Low Risk Pulmonary Embolism Decision Rule – A new decision score for low risk Pulmonary Embolism
  68. A Review on Advanced Atrioventricular Block in Young or Middle‐Aged Adults
  69. Should We Rely on Risk Assessment by the CHADS2 Score in Patients With Non-Valvular Atrial Fibrillation Undergoing Direct Current Cardioversion?
  70. Is there a need for adjusting the results of the recent meta-analysis on the novel oral anticoagulants in atrial fibrillation to the baseline CHADS2 score?
  71. Glomerular filtration rate: Which formula should be used in patients with myocardial infarction?
  72. Taxa de filtração glomerular: que fórmula deverá ser usada em doentes com enfarte agudo do miocárdio?
  73. Fever outperforms flecainide test in the unmasking of type 1 Brugada syndrome electrocardiogram
  74. Pulmonary dissection during diagnostic pulmonary angiography
  75. Hypertension in pregnancy: The current state of the art
  76. Hipertensão arterial na grávida: o atual estado da arte
  77. Thromboembolic Risk in Atrial Flutter Resembles Non-Valvular Atrial Fibrillation (Insights from Transesophageal Echocardiography)
  78. Encerramento percutâneo de defeitos do septo interauricular guiado por ecocardiograma intracardíaco − A experiência de um centro
  79. Intracardiac echocardiography imaging for device closure of atrial septal defects—A single-center experience
  80. Mitral regurgitation during a myocardial infarction – New predictors and prognostic significance at two years of follow-up
  81. Risk stratification of patients with atrial fibrillation: Biomarkers and other future perspectives
  82. Transient loss of consciousness in young adults
  83. Predição do risco de evento cerebrovascular após um enfarte agudo do miocárdio
  84. Prediction of cerebrovascular event risk following myocardial infarction
  85. Cardiac mass in a patient with colorectal cancer: “Not all that glitters is gold!”
  86. Headache and cardiovascular disease: old symptoms, new proposals
  87. Telangiectasia hereditária hemorrágica: causa rara de hipertensão pulmonar?
  88. Aquarium sign in sepsis
  89. Cerebellar abscess by Gemella morbillorum in a patient with inter-atrial communication